NCT00381875View on ClinicalTrials.gov

Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Nonneoplastic Condition
Interventions
BIOLOGICAL

E1M184V peptide vaccine

BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

sargramostim

OTHER

immunoenzyme technique

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00381875 - Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV | Biotech Hunter | Biotech Hunter